- 2024,11,05
Medicine benefits humanity, technology creates the future. On October 29th, a reporter from Henan Radio and Television Station's Elephant News visited Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (referred to as "Cheng Yi Pharmaceutical"), a leader in marine biopharmaceuticals, to visit the Zhejiang Provincial Digital Intelligent Workshop. Host Wang Jing and Zhao Chunjian, General Manager of Zhejiang Cheng Yi Pharmaceutical Co., Ltd., and Li Shisheng, Deputy General Manager, led everyone to deeply explore the leading path of national brands from research and development, raw materials, production, and other aspects.
Aerial image of Zhejiang Cheng Yi Pharmaceutical Co., Ltd
Cheng Yi Pharmaceutical is the first listed company in Zhejiang Province's marine biopharmaceutical industry. In the early stages of development, leveraging the advantages of marine resources, it extracted chitin from crab and shrimp shells and developed glucosamine hydrochloride capsules. After more than 20 years of development, it has achieved a leading position in national technology. Currently, this product has the largest sales volume among similar products in China, accounting for over 41% of the national clinical market share. It is worth mentioning that the product is independently processed by Cheng Yi Pharmaceutical from the source raw materials to the finished formulation, and it is currently the only domestic manufacturer that integrates the raw materials and formulations of glucosamine hydrochloride. At the same time, in order to meet the needs of different groups of people, Cheng Yi Pharmaceutical produces various specifications of products without adding any auxiliary materials, maximizing product effectiveness.
Cheng Yi Pharmaceutical Deputy General Manager Li Shisheng introduces the product to the host
At present, Cheng Yi Pharmaceutical is continuously increasing its research and development investment in marine biopharmaceuticals, and can produce more than 70 varieties and nearly a hundred specifications of drugs and health foods, especially for diseases in middle-aged and elderly people. It has sincerely launched a large health product matrix: for the prevention and treatment of systemic osteoarthritis, it has developed and launched medicinal glucosamine, and achieved the largest scale of raw materials in the country; Developed super fish oil for cardiovascular and cerebrovascular diseases; We have developed a series of neural acid products targeting neurological diseases; We have developed a series of cicada flower cordyceps products targeting sleep disorders; We have developed nine series of immortal grass products, including Dendrobium officinale powder, targeting immune diseases.
Leading scientific research technology inevitably has strict requirements for production conditions. Following the camera of Elephant News, we walked into Cheng Yi Pharmaceutical's formulation workshop together to explore the production line of the star product, Glucosamine Hydrochloride Capsules.
Cheng Yi Pharmaceutical General Manager Zhao Chunjian leads the host to visit the formulation workshop
Zhao Chunjian, General Manager of Cheng Yi Pharmaceutical, introduced that Cheng Yi Pharmaceutical has built a fully accessible "smart factory" for automated, information-based, intelligent, and standardized comprehensive preparations, as well as a 300 acre garden style health industry park.
In addition to glucosamine hydrochloride capsules, Cheng Yi Pharmaceutical's other star product, high-purity fish oil, has the following four characteristics: high-tech, which insists on the integration of fish oil raw materials and preparations, and fish oil purification and separation technology has reached the international advanced level; High purity, mastering key technologies, and controlling the purity and impurities of EPA and DHA at the leading level in the industry; High benchmark, 96% EPA content medicinal high-purity fish oil, original VASCEPA from the United States ® Approved by the FDA and approved for marketing in China in June 2023, over 8000 clinical trials have shown that taking high-purity fish oil reduces the risk of cardiovascular and cerebrovascular diseases by about 30% year-on-year; High quality, the enterprise has established a strict international GMP certification system and a complete quality control system.
We need to make products that people can trust in order to have confidence, "said Yan Yiyi, Chairman of Cheng Yi Pharmaceutical, in an interview.
Cheng Yi Pharmaceutical Chairman Yan Yiyi accepted an interview with Elephant News
For over half a century, Cheng Yi Pharmaceutical has always kept in mind its mission of "continuous development" and "making further contributions", from a workshop style military family small factory with "two large tanks" to becoming a leading enterprise in domestic marine medicine. It closely focuses on the three development directions of "marine medicine, biomedicine, and traditional Chinese medicine" and the "billion dollar market value, century old enterprise" double hundred goal. Currently, it has formed a development model centered on Shanghai, with "front store, back factory" and "headquarters leading".
It is reported that during the 14th Five Year Plan period, Cheng Yi Pharmaceutical actively responded to the national strategy of building a marine economy demonstration zone, planning to build the largest annual production of 2000 tons of glucosamine raw materials and 1000 tons of super fish oil industry in Asia, accelerating the development of the "two strong and one large" project in the big health industry, realizing the full process, full category, and full industry chain layout from food to health products to drugs, accelerating the promotion of group and high-quality development, and striving to build the "aircraft carrier" of Zhejiang Southern Medicine.
Reprinted from: Elephant News